Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates

Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates

<jats:p>Despite the rapid creation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines, the precise correlates of immunity against severe Coronavirus Disease 2019 (COVID-19) are still unknown. Neutralizing antibodies represent a robust surrogate of protection in early Phas...

Full description

Bibliographic Details
Main Authors: Zhu, Daniel Y, Gorman, Matthew J, Yuan, Dansu, Yu, Jingyou, Mercado, Noe B, McMahan, Katherine, Borducchi, Erica N, Lifton, Michelle, Liu, Jinyan, Nampanya, Felix, Patel, Shivani, Peter, Lauren, Tostanoski, Lisa H, Pessaint, Laurent, Van Ry, Alex, Finneyfrock, Brad, Velasco, Jason, Teow, Elyse, Brown, Renita, Cook, Anthony, Andersen, Hanne, Lewis, Mark G, Lauffenburger, Douglas A, Barouch, Dan H, Alter, Galit
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023
Online Access:https://hdl.handle.net/1721.1/147859

Internet

https://hdl.handle.net/1721.1/147859

Similar Items